• Non ci sono risultati.

Progress in Inflammation Research

N/A
N/A
Protected

Academic year: 2022

Condividi "Progress in Inflammation Research"

Copied!
8
0
0

Testo completo

(1)

Series Editor

Prof. Michael J. Parnham PhD Senior Scientific Advisor PLIVA Research Institute Ltd.

Prilaz baruna Filipovic´a 29 HR-10000 Zagreb Croatia

Progress in Inflammation Research

Forthcoming titles:

Chemokine Biology: Basic Research and Clinical Appliation, Volume II: Pathophysiology of Chemokines, K. Neote, G.L. Letts, B. Moser (Editors), 2006

Endothelial Dysfunction and Inflammation, A. Graham (Editor), 2006

In vivo Models of Inflammation, 2nd edition, C. S. Stevenson, D. W. Morgan, L. A. Marshall (Editors), 2006

Lymphocyte Trafficking in Health and Disease, R. Badolato, S. Sozzani (Editors), 2006 The Resolution of Inflammation, A.G. Rossi, D.A. Sawatzky (Editors), 2006

(Already published titles see last page.) Advisory Board

G. Z. Feuerstein (Wyeth Research, Collegeville, PA, USA)

M. Pairet (Boehringer Ingelheim Pharma KG, Biberach a. d. Riss, Germany) W. van Eden (Universiteit Utrecht, Utrecht, The Netherlands)

(2)

Birkhäuser Verlag Basel · Boston · Berlin

The Hereditary Basis of Rheumatic Diseases

Rikard Holmdahl Editor

(3)

ISBN-10: 3-7643-7201-X Birkhäuser Verlag, Basel – Boston – Berlin ISBN-13: 978-3-7643-7201-9 Birkhäuser Verlag, Basel – Boston – Berlin

The publisher and editor can give no guarantee for the information on drug dosage and administration contained in this publication. The respective user must check its accuracy by consulting other sources of reference in each individual case.

The use of registered names, trademarks etc. in this publication, even if not identified as such, does not imply that they are exempt from the relevant protective laws and regulations or free for general use.

This work is subject to copyright. All rights are reserved, whether the whole or part of the material is concerned, specifically the rights of translation, reprinting, re-use of illustrations, recitation, broadcasting, reproduction on micro- films or in other ways, and storage in data banks. For any kind of use, permission of the copyright owner must be obtained.

© 2006 Birkhäuser Verlag, P.O. Box 133, CH-4010 Basel, Switzerland Part of Springer Science+Business Media

Printed on acid-free paper produced from chlorine-free pulp. TCF ∞ Cover design: Markus Etterich, Basel

Cover illustration: Infiltration of CD4 positive T cells and expression of MHC class II synovial lining cells in pannus tissue from a rheumatoid arthritic joint. By courtesy of Rikard Holmdahl and Lars Klareskog.

Printed in Germany

ISBN-10: 3-7643-7201-X e-ISBN-10: 3-7643-7419-5

ISBN-13: 978-3-7643-7201-9 e-ISBN-13: 978-3-7643-7419-8

9 8 7 6 5 4 3 2 1 www.birkhauser.ch

Editor Rikard Holmdahl

Section for Medical Inflammation Research

Department of Cell and Molecular Biology

Lund University Solvegatan 19, I11 BMC S-221 84 Lund Sweden

Library of Congress Cataloging-in-Publication Data

The hereditary basis of rheumatic diseases / Rikard Holmdahl, editor.

p. ; cm. -- (Progress in inflammation research) Includes bibliographical references and index.

ISBN-13: 978-3-7643-7201-9 (alk. paper) ISBN-10: 3-7643-7201-X (alk. paper) ISBN-13: 978-3-7643-7419-8 (e-ISBN) ISBN-10: 3-7643-7419-5 (e-ISBN)

1. Rheumatism--Genetic aspects. I. Holmdahl, Rikard, 1953- II. PIR (Series) RC927.H47 2006

616.7’23042--dc22

2006040762 Bibliographic information published by Die Deutsche Bibliothek

Die Deutsche Bibliothek lists this publication in the Deutsche Nationalbibliografie;

detailed bibliographic data is available in the internet at http://dnb.ddb.de

(4)

List of contributors . . . vii A. Introduction

Rikard Holmdahl

Genetics of joint inflammation – problems and possibilities . . . 3 B. Genetic studies on rheumatic diseases

Jane Worthington, Anne Barton and Sally L. John

The epidemiology of rheumatoid arthritis and the use of linkage and

association studies to identify disease genes . . . 9 Cornelis L. Verweij and Tineke C.T.M. van der Pouw Kraan

Heterogeneity in rheumatoid arthritis based on expression analysis:

towards personalised medicine. . . 29 Ryo Yamada and Kazuhiko Yamamoto

Gene-based large scale LD-mapping of rheumatoid arthritis-

associated genes. . . 43 C. Shared heredity of rheumatic diseases

Peter K. Gregersen and Robert M. Plenge

Emerging relationships: rheumatoid arthritis and the PTPN22 associated

autoimmune disorders. . . 61 Marta E. Alarcón-Riquelme and Sergey V. Kozyrev

Shared genes in rheumatic diseases, the role of PD1 and the RUNX genes

in disease susceptibility. . . 79 Joachim Sieper and Martin Rudwaleit

The role of B27 and other genes associated with ankylosing spondylitis . . . 89

Contents

(5)

D. Tools for analysing complexity

Ulf D. Landegren

Emerging tools for dissecting complex disease . . . 107 Thomas Häupl, Andreas Grützkau, Joachim Grün, Andreas Radbruch

and Gerd-R. Burmester

Expression analysis of rheumatic diseases, prospects and problems. . . 119 Kary A. Latham, Timothy D. Kayes, Zhaohui Qian and Edward F. Rosloniec

The use of humanized MHC mouse strains for studies of

rheumatic diseases . . . 131 Shimon Sakaguchi, Takeshi Takahashi, Hiroshi Hata, Hiroyuki Yoshitomi,

Satoshi Tanaka, Keiji Hirota, Takashi Nomura and Noriko Sakaguchi SKG mice, a monogenic model of autoimmune arthritis due to

altered signal transduction in T-cells . . . 147 Peter J. Olofsson

A genetic approach to select and validate new targets for treatment of

rheumatic diseases. . . 161 Index . . . 175

(6)

vii Marta E. Alarcón-Riquelme, Department of Genetics and Pathology, Rudbeck Lab- oratory, Uppsala University, Dag Hammarskjölds väg 20, 751 85 Uppsala, Sweden;

e-mail: marta.alarcon@genpat.uu.se

Anne Barton, Arthritis Research Campaign Epidemiology Unit, University of Man- chester, Manchester, M13 9PT, UK

Gerd-R. Burmester, Department of Rheumatology and Clinical Immunology, Char- ité University Hospital, Schumannstrasse 20/21, 10117 Berlin, Germany;

e-mail: gerd.burmester@charite.de

Peter K. Gregersen, Robert S. Boas Center for Genomics and Human Genetics, The Feinstein Institute for Medical Research, North Shore LIJ Health System, 350 Com- munity Drive, Manhasset, New York 11030, USA; e-mail: peterg@nshs.edu Joachim Grün, oligene GmbH, Schumannstrasse 20/21, 10117 Berlin, Germany;

e-mail: gruen@drfz.de

Andreas Grützkau, German Arthritis Research Center, Schumannstrasse 20/21, 10117 Berlin, Germany; e-mail: gruetzkau@drfz.de

Thomas Häupl, Department of Rheumatology and Clinical Immunology, Charité University Hospital, Tucholskystrasse 2, 10117 Berlin, Germany;

e-mail: thomas.haeupl@charite.de

Hiroshi Hata, Department of Experimental Pathology, Institute for Frontier Med- ical Sciences, Kyoto University, 53 Shogoin Kawahara-cho, Sakyo-ku, Kyoto 606- 8507, Japan

Keiji Hirota, Department of Experimental Pathology, Institute for Frontier Medical Sciences, Kyoto University, 53 Shogoin Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan

List of contributors

(7)

viii

Rikard Holmdahl, Medical Inflammation Research, BMC I11, Lund University, S- 22184 Lund, Sweden; e-mail: Rikard.Holmdahl@med.lu.se

Sally L. John, Arthritis Research Campaign Epidemiology Unit, University of Man- chester, Manchester, M13 9PT, UK

Timothy D. Kayes, Department of Pathology, University of Tennessee Health Sci- ence Center, Memphis, TN 38163, USA; e-mail: tkayes@utmem.edu

Sergey V. Kozyrev, Department of Genetics and Pathology, Rudbeck Laboratory, Uppsala University, Dag Hammarskjölds väg 20, 751 85 Uppsala, Sweden

Ulf D. Landegren, Department of Genetics and Pathology/Molecular Medicine, Rudbeck Laboratory, Dag Hammarskjoldvag 20, 75185 Uppsala, Sweden;

e-mail: ulf.landegren@genpat.uu.se

Kary A. Latham, Department of Medicine, University of Tennessee Health Science Center, Memphis, TN 38163, USA; e-mail: klatham@utmem.edu

Takashi Nomura, Department of Experimental Pathology, Institute for Frontier Medical Sciences, Kyoto University, 53 Shogoin Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan

Peter Olofsson, Arexis AB, Arvid Wallgrens Backe 20, 41346 Göteborg, Sweden;

e-mail: peter.olofsson@arexis.com

Robert M. Plenge, Broad Institute of MIT and Harvard, Division of Rheumatology, Allergy and Immunology, Brigham and Women’s Hospital, Cambridge, MA, USA Zhaohui Qian, Department of Medicine, University of Tennessee Health Science Center, Memphis, TN 38163, USA; e-mail: zqian@utmem.edu

Andreas Radbruch, German Arthritis Research Center, Schumannstrasse 20/21, 10117 Berlin, Germany; e-mail: radbruch@drfz.de

Edward F. Rosloniec, Departments of Medicine and Pathology, University of Ten- nessee Health Science Center, Memphis, TN 38163, and Veterans Affairs Medical Center, Memphis, TN 38104, USA; e-mail: erosloniec@utmem.edu

Martin Rudwaleit, Rheumatology, Department of Medicine , Charitè, Campus Ben- jamin Franklin, Hindenburgdamm 30, 12200 Berlin, Germany

List of contributors

(8)

Noriko Sakaguchi, Department of Experimental Pathology, Institute for Frontier Medical Sciences, Kyoto University, 53 Shogoin Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan; e-mail: norikos@frontier.kyoto-u.ac.jp

Shimon Sakaguchi, Department of Experimental Pathology, Institute for Frontier Medical Sciences, Kyoto University, 53 Shogoin Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan; e-mail: shimon@frontier.kyoto-u.ac.jp

Joachim Sieper, Rheumatology, Department of Medicine , Charitè, Campus Ben- jamin Franklin, Hindenburgdamm 30, 12200 Berlin, Germany;

e-mail: joachim.sieper@charite.de

Takeshi Takahashi, Department of Experimental Pathology, Institute for Frontier Medical Sciences, Kyoto University, 53 Shogoin Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan

Satoshi Tanaka, Department of Experimental Pathology, Institute for Frontier Med- ical Sciences, Kyoto University, 53 Shogoin Kawahara-cho, Sakyo-ku, Kyoto 606- 8507, Japan

Tineke C.T.M. van der Pouw Kraan, Department of Molecular Cell Biology and Immunology, C270, VU Medical Centre, P.O. Box 7057, 1007 MB Amsterdam, The Netherlands

Cornelis L. Verweij, Department of Molecular Cell Biology and Immunology, C270, VU Medical Centre, P.O. Box 7057, 1007 MB Amsterdam, The Netherlands;

e-mail: c.verweij@vumc.nl

Jane Worthington, Arthritis Research Campaign Epidemiology Unit, University of Manchester, Manchester, M13 9PT, UK; e-mail: Jane.Worthington@man.ac.uk Ryo Yamada, Laboratory for Rheumatic Diseases, SNP Research Center (E508), RIKEN, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, Kanagawa-ken 230-0045, Japan; e-mail: ryamada@src.riken.go.jp

Kazuhiko Yamamoto, Laboratory for Rheumatic Diseases, SNP Research Center (E508), RIKEN, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, Kanagawa-ken 230- 0045, Japan; and Department of Allergy and Rheumatology, Graduate School of Medicine, University of Tokyo, Tokyo 113-8655, Japan

Hiroyuki Yoshitomi, Department of Experimental Pathology, Institute for Frontier Medical Sciences, Kyoto University, 53 Shogoin Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan

ix

List of contributors

Riferimenti

Documenti correlati

Aims of the study are to improve feed formulation and optimize feed additives such taurine, as well as butyrate, salt of a short chain fatty acid (SCFA), to protect fish intestine

L'Unione Europea, per evitare che il Protocollo perdesse la sua efficacia legale subordinata alla ratifica di un numero di Paesi industrializzati costituenti almeno il

Although initially regarded as a co-factor for the potent production of IFN-)I by murine and human immune cells, the effector role of IL-18 has gradually

In [PSr] cells, most of the Sup35 is converted from a soluble, ac- tive state into an insoluble, inactive state similar to the mammalian prion amyloid.. As with mammalian prions,

^Department of Neuropathology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University ^Department of Pathology, Oha- shi Hospital, Toho University

L’ ITALIA HA CENTRATO L’OBIETTIVO DEL

Black, Department of Neurology and Center for Neuroscience and Regen- eration Research, Yale University School of Medicine, New Haven, CT 06510, and Rehabilitation Research Center,

Braun, Laboratory of Cellular Carcinogenesis and Tumor Promotion, National Cancer Institute, Bethesda, MD 20892, USA;.